Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pieris begins phase I trial of anticalin PRS-050 in cancer

June 17, 2010

Galera to advance dismutase mimetics for prevention of oral mucositis

June 17, 2010

Idarubicin/busulphan improves outcome of autograft in patients with NPM1-mutant AML

June 17, 2010

Endocyte presents interim phase I data on FR-targeting conjugates in solid tumors

June 17, 2010

ExonHit and Genmab sign agreement on new potential breast cancer targets

June 17, 2010

MerLion Pharmaceuticals claims new macrolides

June 17, 2010

COMP recommends orphan drug status for 2B3-101 in glioma

June 16, 2010

Celsion to report on phase I/II DIGNITY trial in recurrent chest wall breast cancer

June 16, 2010

Interim phase II data disclosed on PF-00299804 in recurrent/metastatic SCCHN

June 16, 2010

Safety and preliminary antitumor activity of OSI-027 seen in ongoing first-in-man trial

June 16, 2010

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026